Marksans Pharma Ltd announced on Friday that it has received final approval from the US Food and Drug Administration for its generic version of Famotidine tablets, which are used to treat acid indigestion and heartburn. The US Food and Drug Admini...
Bayer AG plans to spend $1 billion on drug research and development in the United States this year as it seeks to double its sales in the country by the end of the decade, according to the company's top U.S. pharmaceutical executive....
Amphastar Pharmaceuticals Inc announced that the FDA had approved its nasal spray for the emergency treatment of known or suspected opioid overdose...
Grifols, one of the world’s leading producers of plasma-derived medicines, announced a global collaboration and licensing agreement with Selagine Inc, a company focused on developing novel therapeutics for ocular diseases, to treat dry eye disease...
Natco Pharma's intraday chart revealed a sharp spike immediately after the buyback news, with the stock reaching Rs 580 per share on Wednesday, up 2.5 percent from Monday's close. The Indian equity markets were closed on Tuesday due to the Holi...
Quest Diagnostics, the world's leading provider of diagnostic information services, announced that its board of directors elected James E. Davis, the company's chief executive officer and president, to serve in the additional position of chairman...
Merck & Co Inc said in a late-stage study that its experimental therapy helped improve exercise capacity in patients with a deadly disease that causes high pressure in blood vessels of the heart and lungs, lifting its shares by about 4%...
Sun Pharma has announced the completion of its acquisition of Concert Pharmaceuticals, headquartered in the United States. In January, the Mumbai-based firm agreed to buy Concert for USD 576 million....
Alembic Pharmaceuticals, an Indian pharmaceutical company, rebounded on Monday, gaining 4% after reaching a 52-week low last week...
Pfizer has sold its rights to a nearly 54-acre land parcel in the Trans-Thane Creek Industrial Area (TTCIA) near Mumbai to Vidhi Research & Development LLP for more than Rs 207 crore, including a differential premium to the Maharashtra Industrial...
, CDSCO.jpg)
